Dexcom and Abbott are each partnering with Insulet to create an automated insulin delivery system

Get the Full StoryThis story was delivered to Business Insider Intelligence Digital Health Pro subscribers earlier this morning.

To get this story plus others to your inbox each day, hours before they're published on Business Insider, click here.

Medtech giants Dexcom and Abbott tied up with insulin pump maker Insulet in separate partnerships that involve integrating Insulet's Omnipod insulin delivery system with their continuous glucose monitors CGMs , according to MobiHealthNews.

Business Insider Intelligence

For context, CGMs keep tabs on diabetics' blood sugar levels throughout the day and alert them of unsafe levels, and Insulet's system utilizes a tube-free, wearable "Pod" that delivers insulin to patients for 72 hours at a time.See the rest of the story at Business InsiderSee Also:We got an exclusive look at the slide deck that Troy Medicare is using to raise 25 million for its unique approach to the red-hot Medicare Advantage marketAmazon's telehealth service, Amazon Care is one step closer to a public launchNebula Genomics rolled out a low-cost genome sequencing test to consumers

Share:

More in Business...

Just east of downtown LA, a toxic recycling plant has operated without a permit for 9 years. Residents want it gone

In San Francisco, a former parking lot is now home to 131 affordable apartments

The 3 most common styles of toxic leadership

From shrimp leather to synthetic dye, are biomaterials finally ready to scale up?

Ring customers can expect a payment from the FTC, thanks to a video privacy settlement